TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates

TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of$ 0.21. This compares to loss of $0.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -19.05%. A quarter ago, it was expected that this company would post a loss of$ 0.23 per share when it actually produced a loss of $0.23, delivering no surprise.Over the last four quarters, the company has not been able to ...